SPS

Post-LOE

sodium polystyrene sulfonate

CMP Pharma

ANDAORAL, RECTALSUSPENSION

Approved

Dec 1982

Lifecycle

Post-LOE

Competitive Pressure

30/100

Clinical Trials

Data completeness

3/8 — Basic

SPS (sodium polystyrene sulfonate) by CMP Pharma is potassium ion exchange activity [moa]. First approved in 1982.

Drug data last refreshed Yesterday

Mechanism of Action

Potassium Ion Exchange Activity

Pharmacologic Class:

Potassium Binder

Indications

Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.

Clinical Trials (11)

NCT06970847Phase 3Recruiting

64Cu-SAR-bisPSMA Positron Emission Tomography: A Phase 3 Study of Participants With Biochemical Recurrence of Prostate Cancer

Started May 2025

220 enrolled

Prostate CancerProstate Cancer Patients With Detectable PSA Following ProstatectomyProstate Cancer Recurrent+3 more

NCT06750835N/ANot Yet Recruiting

Efficacy of the Serratus Posterior Superior Intercostal Plane Block for Postoperative Analgesia in Breast Cancer Surger.(SPSIP) Block is a Novel Regional Anesthesia Technique Targeting the Dorsal Rami and Intercostal Nerves (T2-T6), Providing Sensory Blockade to Both the Posterior and Lateral Aspect

Started Jan 2025

90 enrolled

Breast Cancer

NCT06056830Phase 3Recruiting

Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy

Started Dec 2023

383 enrolled

Prostate CancerProstatic Neoplasms

NCT05249127Phase 1/2Completed

64Cu-SAR-bisPSMA for Identification of Participants With Recurrence of Prostate Cancer (COBRA)

Started Apr 2022

52 enrolled

Biochemical Recurrence of Malignant Neoplasm of Prostate

NCT05286840Phase 1/2Unknown

64Cu-SAR-bisPSMA Positron Emission Tomography of Patients With Known or Suspected Prostate Cancer

Started Mar 2022

150 enrolled

Prostate Cancer

Worked on SPS at CMP Pharma? Share your interview experience or compensation data (+7 days Pro)

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.